Boothbay Fund Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,792
| Closed | -$31.5K | – | 1784 |
|
|
2023
Q2 | $31.5K | Hold |
12,792
| – | – | ﹤0.01% | 1473 |
|
|
2023
Q1 | $28.9K | Hold |
12,792
| – | – | ﹤0.01% | 1796 |
|
|
2022
Q4 | $44.6K | Buy |
+12,792
| New | +$44.6K | ﹤0.01% | 1635 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2245 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2256 |
|
|
2021
Q3 | – | Sell |
-34,353
| Closed | -$1.1M | – | 1905 |
|
|
2021
Q2 | $1.1M | Buy |
34,353
+1,142
| +3% | +$36.6K | 0.04% | 553 |
|
|
2021
Q1 | $1.17M | Buy |
+33,211
| New | +$1.17M | 0.04% | 418 |
|